Credit Suisse Group lowered shares of GreenLight Biosciences (NASDAQ:GRNA – Get Rating) from an outperform rating to a neutral rating in a research report released on Monday morning, The Fly reports. A number of other equities analysts have also weighed in on GRNA. Canaccord Genuity Group assumed coverage on shares of GreenLight Biosciences in a […]